SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,376,000 | -59.8% | 429,063 | -50.0% | 0.02% | -54.0% |
| Q4 2020 | $13,379,000 | +49.1% | 857,339 | -9.7% | 0.05% | +38.9% |
| Q3 2020 | $8,976,000 | +0.2% | 949,823 | -5.0% | 0.04% | -10.0% |
| Q2 2020 | $8,958,000 | +40.7% | 999,823 | 0.0% | 0.04% | +2.6% |
| Q1 2020 | $6,369,000 | -23.9% | 999,823 | 0.0% | 0.04% | -11.4% |
| Q4 2019 | $8,369,000 | -7.5% | 999,823 | 0.0% | 0.04% | -29.0% |
| Q3 2019 | $9,048,000 | -16.0% | 999,823 | 0.0% | 0.06% | -15.1% |
| Q2 2019 | $10,768,000 | +12.9% | 999,823 | 0.0% | 0.07% | +19.7% |
| Q1 2019 | $9,538,000 | -16.9% | 999,823 | 0.0% | 0.06% | -35.1% |
| Q4 2018 | $11,478,000 | -47.3% | 999,823 | -22.1% | 0.09% | -34.3% |
| Q3 2018 | $21,762,000 | +19.4% | 1,283,923 | 0.0% | 0.14% | +4.4% |
| Q2 2018 | $18,232,000 | -40.3% | 1,283,923 | -20.1% | 0.14% | -47.1% |
| Q1 2018 | $30,544,000 | -11.9% | 1,607,579 | -23.9% | 0.26% | -13.7% |
| Q4 2017 | $34,659,000 | +9.3% | 2,113,376 | 0.0% | 0.30% | +16.7% |
| Q3 2017 | $31,701,000 | -12.4% | 2,113,376 | -48.6% | 0.26% | -18.7% |
| Q2 2017 | $36,198,000 | +53.6% | 4,113,376 | -9.2% | 0.32% | +63.7% |
| Q1 2017 | $23,561,000 | +90.5% | 4,530,901 | +11.7% | 0.19% | +59.5% |
| Q4 2016 | $12,370,000 | -34.1% | 4,055,876 | 0.0% | 0.12% | -28.8% |
| Q3 2016 | $18,779,000 | -20.0% | 4,055,876 | 0.0% | 0.17% | -30.9% |
| Q2 2016 | $23,484,000 | -4.3% | 4,055,876 | 0.0% | 0.25% | -5.0% |
| Q1 2016 | $24,538,000 | -33.7% | 4,055,876 | 0.0% | 0.26% | -15.6% |
| Q4 2015 | $37,030,000 | +74.8% | 4,055,876 | +8.0% | 0.31% | +56.6% |
| Q3 2015 | $21,183,000 | -40.9% | 3,755,876 | +16.2% | 0.20% | -37.6% |
| Q2 2015 | $35,831,000 | +62.7% | 3,230,932 | +130.0% | 0.31% | +71.6% |
| Q1 2015 | $22,023,000 | +51.6% | 1,404,544 | +47.0% | 0.18% | +23.6% |
| Q4 2014 | $14,531,000 | +55.8% | 955,332 | +10.5% | 0.15% | +26.5% |
| Q3 2014 | $9,327,000 | +16.8% | 864,856 | +65.4% | 0.12% | +19.4% |
| Q2 2014 | $7,983,000 | -15.5% | 522,764 | 0.0% | 0.10% | -18.3% |
| Q1 2014 | $9,452,000 | +60.4% | 522,764 | +23.2% | 0.12% | +44.6% |
| Q4 2013 | $5,894,000 | +217.9% | 424,308 | +140.1% | 0.08% | +219.2% |
| Q3 2013 | $1,854,000 | – | 176,707 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |